SkinBioTherapeutics plc (AIM: SBTX), a life science company focused on skin health, has finalized the commercial terms of its agreement with Croda plc following successful testing of the SkinBiotix™ technology. The agreement includes tiered royalties for SkinBioTherapeutics based on global sales revenues from licensed products derived from their partnership. The original agreement, signed in November…